Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Management of Central Nervous System Tumors.

Kaley T, Nabors LB.

J Natl Compr Canc Netw. 2019 May 1;17(5.5):579-582. doi: 10.6004/jnccn.2019.5012.

PMID:
31117044
2.
3.

Epidemiology, Treatment, and Complications of Central Nervous System Metastases.

Pruitt AA.

Continuum (Minneap Minn). 2017 Dec;23(6, Neuro-oncology):1580-1600. doi: 10.1212/CON.0000000000000551. Review.

PMID:
29200112
4.

Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.

Kim M, Lee DH, Kim Rn HJ, Cho YH, Kim JH, Kwon DH.

Clin Neurol Neurosurg. 2017 Feb;153:93-101. doi: 10.1016/j.clineuro.2016.12.014. Epub 2016 Dec 29.

PMID:
28081463
5.

Pharmacotherapeutic options for treating brain metastases in non-small cell lung cancer.

Metro G, Chiari R, Ricciuti B, Rebonato A, Lupattelli M, Gori S, Bennati C, Castrioto C, Floridi P, Minotti V, Chiarini P, Crinò L.

Expert Opin Pharmacother. 2015;16(17):2601-13. doi: 10.1517/14656566.2015.1094056. Epub 2015 Oct 6.

PMID:
26439599
6.

Systemic treatments for metastatic cutaneous melanoma.

Pasquali S, Hadjinicolaou AV, Chiarion Sileni V, Rossi CR, Mocellin S.

Cochrane Database Syst Rev. 2018 Feb 6;2:CD011123. doi: 10.1002/14651858.CD011123.pub2. Review.

7.

Unyielding progress: recent advances in the treatment of central nervous system neoplasms with radiosurgery and radiation therapy.

Ding D, Yen CP, Starke RM, Lee CC, Sheehan JP.

J Neurooncol. 2014 Sep;119(3):513-29. doi: 10.1007/s11060-014-1501-7. Epub 2014 Aug 14. Review.

PMID:
25119001
8.

Does lung cancer mutation status and targeted therapy predict for outcomes and local control in the setting of brain metastases treated with radiation?

Wang TJ, Saad S, Qureshi YH, Jani A, Nanda T, Yaeh AM, Rozenblat T, Sisti MB, Bruce JN, McKhann GM, Lesser J, Halmos B, Stoopler MB, Lassman AB, Cheng SK, Isaacson SR.

Neuro Oncol. 2015 Jul;17(7):1022-8. doi: 10.1093/neuonc/nov043. Epub 2015 Apr 24.

9.

Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.

Angelov L, Mohammadi AM, Bennett EE, Abbassy M, Elson P, Chao ST, Montgomery JS, Habboub G, Vogelbaum MA, Suh JH, Murphy ES, Ahluwalia MS, Nagel SJ, Barnett GH.

J Neurosurg. 2018 Aug;129(2):366-382. doi: 10.3171/2017.3.JNS162532. Epub 2017 Sep 22.

PMID:
28937324
10.

Molecular subtyping of brain metastases and implications for therapy.

Renfrow JJ, Lesser GJ.

Curr Treat Options Oncol. 2013 Dec;14(4):514-27. doi: 10.1007/s11864-013-0248-2.

PMID:
23907440
11.
12.

The impact of tumor biology on survival and response to radiation therapy among patients with non-small cell lung cancer brain metastases.

Miller JA, Kotecha R, Ahluwalia MS, Mohammadi AM, Suh JH, Barnett GH, Murphy ES, Vogelbaum MA, Angelov L, Chao ST.

Pract Radiat Oncol. 2017 Jul - Aug;7(4):e263-e273. doi: 10.1016/j.prro.2017.01.001. Epub 2017 Jan 5.

PMID:
28254368
13.

Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.

Chen L, Douglass J, Kleinberg L, Ye X, Marciscano AE, Forde PM, Brahmer J, Lipson E, Sharfman W, Hammers H, Naidoo J, Bettegowda C, Lim M, Redmond KJ.

Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):916-925. doi: 10.1016/j.ijrobp.2017.11.041. Epub 2017 Dec 5.

PMID:
29485071
14.

Current therapeutic approaches in patients with brain metastases.

Peacock KH, Lesser GJ.

Curr Treat Options Oncol. 2006 Nov;7(6):479-89. Review.

PMID:
17032560
15.

Management of Leptomeningeal Metastases in Non-oncogene Addicted Non-small Cell Lung Cancer.

Turkaj A, Morelli AM, Vavalà T, Novello S.

Front Oncol. 2018 Jul 27;8:278. doi: 10.3389/fonc.2018.00278. eCollection 2018. Review.

16.

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Treatment Options for Adults With Multiple Metastatic Brain Tumors.

Ammirati M, Nahed BV, Andrews D, Chen CC, Olson JJ.

Neurosurgery. 2019 Mar 1;84(3):E180-E182. doi: 10.1093/neuros/nyy548.

PMID:
30629219
17.

The role of radiosurgery in the management of WHO Grade II and III intracranial meningiomas.

Ding D, Starke RM, Hantzmon J, Yen CP, Williams BJ, Sheehan JP.

Neurosurg Focus. 2013 Dec;35(6):E16. doi: 10.3171/2013.9.FOCUS13364. Review.

PMID:
24289124
18.

Stereotactic Radiosurgery for Treatment of Brain Metastases.

Badiyan SN, Regine WF, Mehta M.

J Oncol Pract. 2016 Aug;12(8):703-12. doi: 10.1200/JOP.2016.012922. Review.

PMID:
27511715
19.

Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.

Iorio-Morin C, Masson-Côté L, Ezahr Y, Blanchard J, Ebacher A, Mathieu D.

J Neurosurg. 2014 Dec;121 Suppl:69-74. doi: 10.3171/2014.7.GKS141488.

PMID:
25434939
20.

Whole-brain radiation therapy for brain metastases: detrimental or beneficial?

Gemici C, Yaprak G.

Radiat Oncol. 2015 Jul 28;10:153. doi: 10.1186/s13014-015-0466-9.

Supplemental Content

Support Center